RecruitingNCT07245927

Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism

An Open, Prospective, Non-interventional, Multicentre, Controlled Study of Safety and Efficacy of the Thrombolysis With the Non-immunogenic Staphylokinase in Patients With Massive Pulmonary Embolism (FORPE Registry)

Sponsor

Supergene, LLC

Enrollment

20,000 participants

Start Date

Jun 1, 2025

Study Type

OBSERVATIONAL

Conditions

Pulmonary Embolism Acute Massive

Summary

The aim of FORPE Registry is to study the safety and efficacy of the non-immunogenic staphylokinase in patients with massive pulmonary embolism in routine clinical practice.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Non-immunogenic staphylokinasenon-immunogenic staphylokinase 15 mg as a single intravenous bolus Other Names: Fortelyzin® for people with pulmonary embolism acute massive. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNon-immunogenic staphylokinasenon-immunogenic staphylokinase 15 mg as a single intravenous bolus Other Names: Fortelyzin®

Non-immunogenic staphylokinase 15 mg as a single intravenous bolus

Locations(14)

Belgorod Regional Clinical Hospital of St. Joseph

Belgorod, Russia

Kuzbass Cardiology center

Kemerovo, Russia

Center of Neurology and Cardiology

Kirov, Russia

Lipetsk City Hospital No. 4 "Lipetsk-Med"

Lipetsk, Russia

E.I. Chazov National Medical Research Center of Cardiology

Moscow, Russia

F.I. Inozemtsev City Clinical Hospital

Moscow, Russia

Moscow Multidisciplinary Clinical Center "Kommunarka"

Moscow, Russia

S.P. Botkin City Clinical Hospital

Moscow, Russia

S.S. Yudin City Clinical Hospital

Moscow, Russia

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital

Nizhny Novgorod, Russia

G.A. Zakharyin Clinical hospital №6

Penza, Russia

V.P. Polyakov Samara Regional Clinical Cardiology Dispensary

Samara, Russia

Tver Regional Clinical Hospital

Tver', Russia

City Clinical Hospital of Emergency medicine №25

Volgograd, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07245927

Related Trials

Early Catheter-directed Treatment of High Risk Pulmonary Embolism

NCT0667208118 locations

Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong

NCT070298411 location

Registry of Catheter Intervention in Pulmonary Embolism

NCT063484591 location